Similar articles

• Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins.

  Rappuoli R, Pizza M, Douce G, Dougan G. Rappuoli R, et al. Immunol Today. 1999 Nov;20(11):493-500. doi: 10.1016/s0167-5699(99)01523-6. Immunol Today. 1999. PMID: 10529776 Review. No abstract available.
• AB5 ADP-ribosylating toxins: comparative anatomy and physiology.

  Burnette WN. Burnette WN. Structure. 1994 Mar 15;2(3):151-8. doi: 10.1016/s0969-2126(00)00017-4. Structure. 1994. PMID: 8069630 Review.
• Structural biology and structure-based inhibitor design of cholera toxin and heat-labile enterotoxin.

  Fan E, O'Neal CJ, Mitchell DD, Robien MA, Zhang Z, Pickens JC, Tan XJ, Korotkov K, Roach C, Krumm B, Verlinde CL, Merritt EA, Hol WG. Fan E, et al. Int J Med Microbiol. 2004 Oct;294(4):217-23. doi: 10.1016/j.ijmm.2004.07.002. Int J Med Microbiol. 2004. PMID: 15532979 Review.
• Cholera toxin and related enterotoxins as potent immune modulators.

  Hirst TR, Nashar TO, Pitman RS, Williams NA. Hirst TR, et al. Symp Ser Soc Appl Microbiol. 1998;27:26S-34S. doi: 10.1046/j.1365-2672.1998.0840s126s.x. Symp Ser Soc Appl Microbiol. 1998. PMID: 9750359 Review. No abstract available.
• Galactose-binding site in Escherichia coli heat-labile enterotoxin (LT) and cholera toxin (CT).

  Merritt EA, Sixma TK, Kalk KH, van Zanten BA, Hol WG. Merritt EA, et al. Mol Microbiol. 1994 Aug;13(4):745-53. doi: 10.1111/j.1365-2958.1994.tb00467.x. Mol Microbiol. 1994. PMID: 7997185